Analysts expect over 2020 rising revenue Novartis, quite high dividend

Novartis will announce it's last quarter's results tomorrow. Over the current book year the total revenue will be 50,27 billion CHF (consensus estimates). This is slightly more than 2019's revenue of 48,62 billion CHF.

Historical revenues and results Novartis plus estimates 2020

The analysts expect for 2020 a net profit of 12,96 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 5,7 CHF. The price/earnings-ratio therefore equals 14,45.

Huge dividend Novartis

Per share the analysts anticipate on a dividend of 3,12 CHF per share. Thus the dividend yield equals 3,79 percent. The average dividend yield of the pharmaceutical companies is a limited 0,21 percent.

Recent target prices around 104 CHF

The most recent recommendations for the pharmaceutical company are from Jefferies & Co., Goldman Sachs and Independent Research.

Novartis's market capitalization is based on the number of outstanding shares around 190,35 billion CHF. The Novartis stock was the past 12 months quite unstable. Since last July the stock is 8 percent lower. This year the stock price moved between 65 and 96 CHF.

Historical stock prices Novartis

Click here for dividend Novartis. At 10.17 the stock trades 0,24 percent lower at 82,36 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.